A.I.dvisor analyzed 915 other stocks in the Biotechnology Industry over the last week and discovered that of them (6) exhibited an Uptrend while of them (3) exhibited a Downtrend.
a clinical-stage biopharmaceutical company, which engages in the development of non-viral gene engineering technologies for the treatment of hematological malignancies and solid tumors